We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CUDA
2201
DELISTED
Barracuda Networks, Inc.
CUDA
| $546K | ﹤0.01% |
23,612
+216
| +0.9% | +$5.05K |
|
2202
Bristow Group
VTOL
$1.34B
| $545K | ﹤0.01% |
20,562
+5,248
| +34% | +$151K |
|
2203
Planet Fitness
PLNT
$4.42B
| $544K | ﹤0.01% |
28,224
+3,603
| +15% | +$74.4K |
|
|
COTV
2204
DELISTED
Cotiviti Holdings, Inc.
COTV
| $544K | ﹤0.01% |
13,069
+217
| +2% | +$7.9K |
|
2205
Independent Bank Corp
IBCP
$787M
| $543K | ﹤0.01% |
26,235
+360
| +1% | +$7.61K |
|
|
NETI
2206
DELISTED
Eneti Inc.
NETI
| $541K | ﹤0.01% |
6,330
+271
| +4% | +$18.9K |
|
2207
Babcock & Wilcox
BW
$1.39B
| $540K | ﹤0.01% |
5,780
+153
| +3% | +$21.4K |
|
|
TAST
2208
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $538K | ﹤0.01% |
38,007
+1,717
| +5% | +$25.6K |
|
2209
Twilio
TWLO
$30B
| $536K | ﹤0.01% |
18,568
+3,428
| +23% | +$104K |
|
2210
Arrow Financial
AROW
$659M
| $535K | ﹤0.01% |
19,416
+528
| +3% | +$15.3K |
|
2211
Sonida Senior Living
SNDA
$1.91B
| $534K | ﹤0.01% |
2,534
+366
| +17% | +$86.9K |
|
2212
Frontline
FRO
$8.76B
| $533K | ﹤0.01% |
79,140
+5,469
| +7% | +$38.2K |
|
|
CNR
2213
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $532K | ﹤0.01% |
31,042
+852
| +3% | +$13.7K |
|
|
EIGI
2214
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $532K | ﹤0.01% |
67,814
+2,915
| +4% | +$23.8K |
|
|
SCMP
2215
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $532K | ﹤0.01% |
48,387
+19,737
| +69% | +$229K |
|
|
WIFI
2216
DELISTED
Boingo Wireless, Inc.
WIFI
| $530K | ﹤0.01% |
40,801
+1,226
| +3% | +$14.6K |
|
|
GBNK
2217
DELISTED
Guaranty Bancorp
GBNK
| $530K | ﹤0.01% |
21,768
+2,356
| +12% | +$57.2K |
|
2218
Beazer Homes USA
BZH
$877M
| $528K | ﹤0.01% |
43,545
+1,066
| +3% | +$13.7K |
|
|
OME
2219
DELISTED
Omega Protein
OME
| $528K | ﹤0.01% |
26,313
+706
| +3% | +$16.4K |
|
2220
Pacific Biosciences
PACB
$435M
| $527K | ﹤0.01% |
101,964
+2,703
| +3% | +$13.2K |
|
|
WSR
2221
DELISTED
Whitestone REIT
WSR
| $526K | ﹤0.01% |
38,020
+4,090
| +12% | +$56.4K |
|
2222
Inovio Pharmaceuticals
INO
$55.7M
| $523K | ﹤0.01% |
6,582
+464
| +8% | +$37K |
|
2223
Kopin
KOPN
$652M
| $523K | ﹤0.01% |
127,449
+33,370
| +35% | +$118K |
|
2224
Westwood Holdings Group
WHG
$182M
| $522K | ﹤0.01% |
9,772
+318
| +3% | +$18.2K |
|
2225
American Coastal Insurance
ACIC
$515M
| $520K | ﹤0.01% |
32,577
+10,298
| +46% | +$160K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.